Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Feb;31(1):3-21.
doi: 10.3109/08830185.2011.637254.

Perspective for prophylaxis and treatment of cervical cancer: an immunological approach

Marjorie Jenkins  1 , Maurizio Chiriva-Internati, Leonardo Mirandola, Catherine Tonroy, Sean S Tedjarati, Nicole Davis, Nicholas D'Cunha, Lukman Tijani, Fred Hardwick, Diane Nguyen, W Martin Kast, Everardo Cobos
Affiliations
Review

Perspective for prophylaxis and treatment of cervical cancer: an immunological approach

Marjorie Jenkins et al. Int Rev Immunol. 2012 Feb.

Abstract

As the second most common cause of cancer-related death in women, human papilloma virus (HPV) vaccines have been a major step in decreasing the morbidity and mortality associated with cervical cancer. An estimated 490,000 women are diagnosed with cervical cancer each year. Increasing knowledge of the HPV role in the etiology of cervical cancer has led to the development and introduction of HPV-based vaccines for active immunotherapy of cervical cancer. Immunotherapies directed at preventing HPV-persistent infections. These vaccines are already accessible for prophylaxis and in the near future, they will be available for the treatment of preexisting HPV-related neoplastic lesions.

PubMed Disclaimer

Conflict of interest statement

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

References

    1. Brinkman JA, Caffrey AS, Muderspach LI, et al. The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: consequences for clinical management. Eur J Gynaecol Oncol. 2005;26:129–142. - PubMed
    1. Kim JJ, Goldie SJ. Health and economic implications of HPV vaccination in the United States. N Engl J Med. 2008;359:821–832. - PMC - PubMed
    1. Kahn JA. HPV vaccination for the prevention of cervical intraepithelial neoplasia. N Engl J Med. 2009;361:271–278. - PubMed
    1. Gershenson DM. Gynecologic Cancer: Controversies in Management. Philadelphia, PA: Elserver; 2004.
    1. Hoskins WJ. Principles and Practive of Gynecologic Oncology. 4. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.

Publication types

MeSH terms

Substances